DCF — SUMMIT PACIFIC MEDICAL CENTER
Enterprise Value: $55.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$55.3M
Enterprise Value
$14.4M
PV of Cash Flows
$40.9M
PV of Terminal Value
$65.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $75.8M | $7.3M | 10.0% | $2.7M | $2.5M |
| Year 2 | $78.0M | $8.3M | 11.0% | $3.4M | $2.8M |
| Year 3 | $80.4M | $9.3M | 12.0% | $4.1M | $3.1M |
| Year 4 | $82.8M | $10.0M | 12.0% | $4.5M | $3.1M |
| Year 5 | $85.3M | $10.5M | 12.0% | $4.8M | $3.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $55.3M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$73.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.09092688858128786
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5